ATE342723T1 - Behandlung von neurodegenerativen gastrointestinalen krankheiten durch implantation von neuralen stammzellen und/oder deren nachkommen in gastrointestinalorgane - Google Patents

Behandlung von neurodegenerativen gastrointestinalen krankheiten durch implantation von neuralen stammzellen und/oder deren nachkommen in gastrointestinalorgane

Info

Publication number
ATE342723T1
ATE342723T1 AT01926922T AT01926922T ATE342723T1 AT E342723 T1 ATE342723 T1 AT E342723T1 AT 01926922 T AT01926922 T AT 01926922T AT 01926922 T AT01926922 T AT 01926922T AT E342723 T1 ATE342723 T1 AT E342723T1
Authority
AT
Austria
Prior art keywords
gastrointestinal
stem cells
progents
neurodegenerative
implantation
Prior art date
Application number
AT01926922T
Other languages
English (en)
Inventor
Pankaj Jay Pasricha
Maria A Micci
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE342723T1 publication Critical patent/ATE342723T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01926922T 2000-04-13 2001-04-12 Behandlung von neurodegenerativen gastrointestinalen krankheiten durch implantation von neuralen stammzellen und/oder deren nachkommen in gastrointestinalorgane ATE342723T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19680600P 2000-04-13 2000-04-13
US23230100P 2000-09-12 2000-09-12

Publications (1)

Publication Number Publication Date
ATE342723T1 true ATE342723T1 (de) 2006-11-15

Family

ID=26892243

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01926922T ATE342723T1 (de) 2000-04-13 2001-04-12 Behandlung von neurodegenerativen gastrointestinalen krankheiten durch implantation von neuralen stammzellen und/oder deren nachkommen in gastrointestinalorgane

Country Status (7)

Country Link
US (1) US6808702B2 (de)
EP (1) EP1272203B1 (de)
JP (1) JP2003531124A (de)
AT (1) ATE342723T1 (de)
AU (1) AU2001253425A1 (de)
DE (1) DE60123937T2 (de)
WO (1) WO2001078752A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0102717D0 (en) * 2001-02-02 2001-03-21 Medical Res Council Cells and uses therefor
CA2473503C (en) 2002-01-14 2010-01-05 The Board Of Trustees Of The University Of Illinois Use of modified pyrimidine compounds to promote stem cell migration and proliferation
US20040071674A1 (en) * 2002-03-19 2004-04-15 Hiroshi Mashimo Therapeutic treatment of digestive organs with engineered stem cells
KR100558811B1 (ko) * 2003-12-16 2006-03-10 엘지전자 주식회사 스크롤 압축기의 밀봉력 조절장치
WO2007016099A2 (en) * 2005-07-29 2007-02-08 Musc Foundation For Research Development Protection of transplanted stem cells with hmg-coa reductase inhibitors
US8021355B2 (en) 2005-08-12 2011-09-20 Board Of Regents The University Of Texas System System, kit, and method of transgastric removal of visceral fat and other related methods
WO2009018626A1 (en) * 2007-08-09 2009-02-12 Murdoch Childrens Research Institute A therapeutic protocol using stem cells in tissue and neuronal repair, maintenance, regeneration and augmentation
JP5294041B2 (ja) * 2008-06-27 2013-09-18 独立行政法人産業技術総合研究所 膵臓疾患又は糖尿病のための膵臓細胞再生移植用キット
US9101570B1 (en) 2009-02-13 2015-08-11 Endocellutions, Inc. Adult and neonatal stem cell therapy to treat diabetes through the repair of the gastrointestinal tract
EP2566500B1 (de) 2010-05-05 2017-04-12 Rappaport Family Institute for Research in the Medical Sciences Ccl1 zur verwendung für therapeutische zwecke
US20170077320A1 (en) * 2015-09-11 2017-03-16 Solarcity Corporation Anti-corrosion protection of photovoltaic structures

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6497872B1 (en) * 1991-07-08 2002-12-24 Neurospheres Holdings Ltd. Neural transplantation using proliferated multipotent neural stem cells and their progeny
US5980885A (en) 1991-07-08 1999-11-09 Neurospheres Holdings Ltd. Growth factor-induced proliferation of neural precursor cells in vivo
US5981165A (en) 1991-07-08 1999-11-09 Neurospheres Holdings Ltd. In vitro induction of dopaminergic cells
US5851832A (en) 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
US5175103A (en) 1991-10-21 1992-12-29 Trustees Of University Of Pennsylvania Preparation of pure cultures of post-mitotic human neurons
US5753491A (en) 1993-04-13 1998-05-19 Us Health Use of neuro-derived fetal cell lines for transplantation therapy
CA2159738A1 (en) 1993-04-13 1994-10-27 Eugene O. Major Use of neuro-derived fetal cell lines for transplantation therapy
US5753505A (en) 1995-07-06 1998-05-19 Emory University Neuronal progenitor cells and uses thereof
EP0934403A4 (de) 1996-08-19 2001-03-14 Univ Massachusetts Embryonische zelllinien oder stammzell-ähnliche zelllinien, die durch kerntransplantation zwischen verschiedenen spezies produziert wurden.
US6025157A (en) 1997-02-18 2000-02-15 Genentech, Inc. Neurturin receptor
US5968829A (en) 1997-09-05 1999-10-19 Cytotherapeutics, Inc. Human CNS neural stem cells
SE9802264D0 (sv) * 1998-06-25 1998-06-25 Neuronova Ab A method of isolating cells
US6129911A (en) * 1998-07-10 2000-10-10 Rhode Island Hospital, A Lifespan Partner Liver stem cell

Also Published As

Publication number Publication date
EP1272203A2 (de) 2003-01-08
JP2003531124A (ja) 2003-10-21
WO2001078752A3 (en) 2002-05-23
EP1272203B1 (de) 2006-10-18
US6808702B2 (en) 2004-10-26
DE60123937T2 (de) 2007-06-14
US20020001578A1 (en) 2002-01-03
AU2001253425A1 (en) 2001-10-30
DE60123937D1 (de) 2006-11-30
WO2001078752A2 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
ATE342723T1 (de) Behandlung von neurodegenerativen gastrointestinalen krankheiten durch implantation von neuralen stammzellen und/oder deren nachkommen in gastrointestinalorgane
Jenner The politics of London air John Evelyn's Fumifugium and the Restoration
BR0112361A (pt) Métodos para tratamento de condições oculares mediadas por inflamação
DK0756498T3 (da) Behandling af biologisk materiale før fiksering
DE69525151T2 (de) Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat
DK2198876T3 (da) Fremgangsmåde til nedsættelse af sandsynligheden for implantationssvigt i et individ
ATE230607T1 (de) Verwendung von neurturin protein zur vorbeugung und behandlung von gehörverlust
AR036401A1 (es) Incremento de la cantidad de celulas madre neuronales inducido por prolactina.
NO20061899L (no) Kunstig biologisk implantat og dets bruk og fremgangsmate for redusering av risikoen for dannelse av bindevev etter implantasjon
CY1108599T1 (el) Η απλιδινη στην αντιμετωπιση του πολλαπλου μυελωματος
WO2008157787A3 (en) Hydroxylated tolans and related compounds in the treatment of cancer
DK0822926T3 (da) Gødning og fremgangsmåde til fremstilling af denne
DK1274464T3 (da) Sammensætninger og fremgangsmåder til regulering af proteinekspression i tarm
Emke Why the sad face? Secularization and the changing function of funerals in Newfoundland
WO2001021220A3 (en) Bioprosthetic heart valves
DE69721747D1 (de) Methode zur behandlung oder verhütung von interstitieller blasenentzundung
Kempf ‘The second coming of the Lord’: early christianization, episodic time, and the cultural construction of continuity in Sibog
DE60318081D1 (de) Verwendung von brimonidine zur behandlung von dementia und morbus parkinson
ATE268170T1 (de) Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz
Glazebrook Heideggerian ecofeminism
Dahlgren ‘She brings up healthy children for the homeland’: morality discourses in Yemeni legal debates
Samoura African Commission of Health and Human Rights Promoters
RU99116658A (ru) Способ лечения ишемической болезни сердца, стенокардии напряжения i-п функциональных классов
Salwa Historic Gardens as Places of Conflicting Values
Rotar On Cremation in Nowadays Romania

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties